Actinium Pharmaceuticals names Matt David chief financial officer
ATNM•Actinium Pharmaceuticals appointed Matt David chief financial officer to lead financial operations, capital markets and investor relations.
1. Finance leadership appointment
David most recently served as CorMedix's executive vice president and chief business officer, after joining the company as chief financial officer in 2020. His background includes more than two decades in biopharmaceutical leadership, healthcare investment banking and equity research.
